Needham & Company Upgrades Hologic (HOLX) to Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq fall, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Spain's ex-transport minister sentenced to 24 years for corruption
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
Leerink Partners Remains Bullish on Hologic (HOLX) as Lower Tax Rate Helps Drive 1Q Results
January 28, 2016 9:31 AM ESTLeerink Partners maintained an Outperform rating on Hologic (NASDAQ: HOLX), and cut the price target to $44.00 (from $47.00), following the company's 1Q earnings report. HOLX reported revenue of $695M, which was $6M ahead of the Street's estimate, with outperformance primarily from GYN and... More
Hologic (HOLX) Tops Q1 EPS by 4c; Guides FY EPS Higher
January 27, 2016 4:07 PM ESTHologic (NASDAQ: HOLX) reported Q1 EPS of $0.46, $0.04 better than the analyst estimate of $0.42. Revenue for the quarter came in at $695.2 million versus the consensus estimate of $688.04 million.
GUIDANCE:
Hologic sees Q2 2016 EPS of $0.45-$0.46, versus the consensus of $0.45. Hologic sees Q2... More
